CBD Monthly Update — July 2020

We gathered the top CBD news from this month to keep you in the loop.

July 9, 2020

1 Min Read

Hemp Collective podcast episode 5: Hemp Collective Virtual Summit rewind – podcast

In this month's podcast, we provide a snapshot of the regulatory, quality, market data and industry action items covered during the Hemp Collective Virtual Summit in May. We explore consumer insights driving industry growth, top issues related to quality and the biggest legal challenges companies face today.

Research backs CBD for arthritis in dogs

A study published in the Journal of Immunology found that after a month of daily CBD, dogs with canine osteoarthritis showed significant improvement in their mobility and quality of life. The U.S. pet CBD market is projected to reach $563 million in sales this year. Read more at Forbes...

How CBD might reduce COVID-19 lung inflammation

Nebraska and the Texas Biomedical Research Institute detail the evidence for how cannabinoids’ anti-inflammatory powers may help treat dangerous lung inflammation from the disease in an article in Brain, Behavior and Immunity.

84% of CBD consumers believe CBD can replace opioids

A recent AmericanMarijuana.org survey of 1,450 CBD consumers revealed that most use the product to treat chronic pain—and believe CBD is an effective replacement for opioids. Read more at AmericanMarijuana.org...

Military moves to criminalize CBD

A Department of Defense tweet recently highlighted a February memo by the Acting Under Secretary of Defense of Personnel and Readiness that says troops can be punished for using products containing hemp or cannabidiol. Read more at Military.com...

Want to receive these updates directly to your inbox each month? Sign up here, and also get a copy of Demystifying CBD, one question at a time.



Subscribe and receive the latest updates on trends, data, events and more.
Join 57,000+ members of the natural products community.

You May Also Like